Summary

Radiation Dose Management Market – Scope of Report
TMR’s report on the global radiation dose management market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global radiation dose management market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global radiation dose management market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the radiation dose management market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global radiation dose management market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global radiation dose management market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global radiation dose management market.

The report delves into the competitive landscape of the global radiation dose management market. Key players operating in the global radiation dose management market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global radiation dose management market profiled in this report.

Key Questions Answered in Global radiation dose management Market Report
• What is the sales/revenue generated by radiation dose management across all regions during the forecast period?
• What are the opportunities in the global radiation dose management market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Radiation Dose Management Market – Research Objectives and Research Approach
The comprehensive report on the global radiation dose management market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global radiation dose management market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global radiation dose management market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiation Dose Management Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiation Dose Management Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Radiation Dose Management Market Analysis and Forecast, by Product and Services
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product and Services, 2017–2031
6.3.1. Software
6.3.1.1. Integrated Solution
6.3.1.2. Standalone Solution
6.3.2. Services
6.4. Market Attractiveness, by Product and Services
7. Global Radiation Dose Management Market Analysis and Forecast, by Modality
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Modality, 2017–2031
7.3.1. Computed Tomography
7.3.2. Radiography and Mammography
7.3.3. Fluoroscopy and Interventional Imaging
7.3.4. Nuclear Medicine Scan
7.3.5. Others
7.3.6. 7.4 Market Attractiveness, by Modality
8. Global Radiation Dose Management Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Oncology
8.3.2. Cardiology
8.3.3. Orthopedic
8.3.4. Others
8.4. Market Attractiveness, by Application
9. Global Radiation Dose Management Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Care Settings
9.3.3. Research Organizations
9.3.4. Others
9.4. Market Attractiveness, by End-user
10. Global Radiation Dose Management Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Radiation Dose Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product and Services, 2017–2031
11.2.1. Software
11.2.1.1. Integrated Solution
11.2.1.2. Standalone Solution
11.2.2. Services
11.3. Market Attractiveness, by Product and Services
11.4. Market Value Forecast, by Modality, 2017–2031
11.4.1. Computed Tomography
11.4.2. Radiography and Mammography
11.4.3. Fluoroscopy and Interventional Imaging
11.4.4. Nuclear Medicine Scan
11.4.5. Others
11.5. Market Attractiveness, by Modality
11.6. Market Value Forecast, by Application, 2017–2031
11.6.1. Oncology
11.6.2. Cardiology
11.6.3. Orthopedic
11.6.4. Others
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals
11.8.2. Ambulatory Care Settings
11.8.3. Research Organizations
11.8.4. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product and Services
11.11.2. By Modality
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Radiation Dose Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product and Services, 2017–2031
12.2.1. Software
12.2.1.1. Integrated Solution
12.2.1.2. Standalone Solution
12.2.2. Services
12.3. Market Attractiveness, by Product and Services
12.4. Market Value Forecast, by Modality, 2017–2031
12.4.1. Computed Tomography
12.4.2. Radiography and Mammography
12.4.3. Fluoroscopy and Interventional Imaging
12.4.4. Nuclear Medicine Scan
12.4.5. Others
12.5. Market Attractiveness, by Modality
12.6. Market Value Forecast, by Application, 2017–2031
12.6.1. Oncology
12.6.2. Cardiology
12.6.3. Orthopedic
12.6.4. Others
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals
12.8.2. Ambulatory Care Settings
12.8.3. Research Organizations
12.8.4. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product and Services
12.11.2. By Modality
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Radiation Dose Management Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product and Services, 2017–2031
13.2.1. Software
13.2.1.1. Integrated Solution
13.2.1.2. Standalone Solution
13.2.2. Services
13.3. Market Attractiveness, by Product and Services
13.4. Market Value Forecast, by Modality, 2017–2031
13.4.1. Computed Tomography
13.4.2. Radiography and Mammography
13.4.3. Fluoroscopy and Interventional Imaging
13.4.4. Nuclear Medicine Scan
13.4.5. Others
13.5. Market Attractiveness, by Modality
13.6. Market Value Forecast, by Application, 2017–2031
13.6.1. Oncology
13.6.2. Cardiology
13.6.3. Orthopedic
13.6.4. Others
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals
13.8.2. Ambulatory Care Settings
13.8.3. Research Organizations
13.8.4. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product and Services
13.11.2. By Modality
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Radiation Dose Management Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product and Services, 2017–2031
14.2.1. Software
14.2.1.1. Integrated Solution
14.2.1.2. Standalone Solution
14.2.2. Services
14.3. Market Attractiveness, by Product and Services
14.4. Market Value Forecast, by Modality, 2017–2031
14.4.1. Computed Tomography
14.4.2. Radiography and Mammography
14.4.3. Fluoroscopy and Interventional Imaging
14.4.4. Nuclear Medicine Scan
14.4.5. Others
14.5. Market Attractiveness, by Modality
14.6. Market Value Forecast, by Application, 2017–2031
14.6.1. Oncology
14.6.2. Cardiology
14.6.3. Orthopedic
14.6.4. Others
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals
14.8.2. Ambulatory Care Settings
14.8.3. Research Organizations
14.8.4. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product and Services
14.11.2. By Modality
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Radiation Dose Management Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product and Services, 2017–2031
15.2.1. Software
15.2.1.1. Integrated Solution
15.2.1.2. Standalone Solution
15.2.2. Services
15.3. Market Attractiveness, by Product and Services
15.4. Market Value Forecast, by Modality, 2017–2031
15.4.1. Computed Tomography
15.4.2. Radiography and Mammography
15.4.3. Fluoroscopy and Interventional Imaging
15.4.4. Nuclear Medicine Scan
15.4.5. Others
15.5. Market Attractiveness, by Modality
15.6. Market Value Forecast, by Application, 2017–2031
15.6.1. Oncology
15.6.2. Cardiology
15.6.3. Orthopedic
15.6.4. Others
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals
15.8.2. Ambulatory Care Settings
15.8.3. Research Organizations
15.8.4. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product and Services
15.11.2. By Modality
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player -Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Landauer
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Agfa-Gevaert Group
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Sectra AB
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. INFINITT Healthcare Co. Ltd.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Bayer AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. PACSHealth, LLC
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Koninklijke Philips N.V.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. GE Healthcare
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Thermo Fisher Scientific, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Medsquare SAS
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Siemens
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Fujifilm Holdings Corporation
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. QAELUM NV
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview